rosiglitazone has been researched along with sildenafil citrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Peuler, JD; Phelps, LE | 1 |
| Ahsan, F; Rashid, J | 1 |
| Ahsan, F; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR | 1 |
| Su, Y; Tang, L; Wang, T; Wang, W; Xiao, Q; Xie, M | 1 |
| Alessio, N; Di Bernardo, G; Di Maio, G; Monda, M; Peluso, G; Perrotta, S | 1 |
6 other study(ies) available for rosiglitazone and sildenafil citrate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arteries; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Metformin; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase 5 Inhibitors; Pioglitazone; Rats; Rosiglitazone; Sildenafil Citrate; Tail; Thiazolidinediones; Vasodilator Agents | 2015 |
A highly sensitive LC-MS/MS method for concurrent determination of sildenafil and rosiglitazone in rat plasma.
Topics: Administration, Intravenous; Animals; Chromatography, Liquid; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Rosiglitazone; Sildenafil Citrate; Tandem Mass Spectrometry; Thiazolidinediones | 2016 |
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
Topics: Administration, Inhalation; Animals; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sildenafil Citrate; Vascular Remodeling | 2019 |
Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Hypoglycemic Agents; Lipoproteins; Lipoproteins, HDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Obese; Nanoparticles; Obesity; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Sildenafil Citrate; Treatment Outcome | 2022 |
Molecular and Physiological Effects of Browning Agents on White Adipocytes from Bone Marrow Mesenchymal Stromal Cells.
Topics: Adipocytes, White; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Bone Marrow; Energy Metabolism; Fibronectins; Glucose; Mammals; Mesenchymal Stem Cells; Rosiglitazone; Sildenafil Citrate; Thermogenesis; Triglycerides | 2022 |